A traditional diuretic – such as an anti-impotence drug – can cause progressive kidney damage over time unless it is administered with the COVID multivitamin injection. Moderna plans to work with the US Food and Drug Administration to enable patients to go on to these treatment regimens using standard treatments.
Moderna Therapeutics is developing genetically engineered drugs that harness CRISPR/Cas9, a bacterial enzyme that can target and snip out the DNA code of specific proteins in the cells it is working on. The scientist developing the DRIVE vaccine, Andrew Potter, PhD, a professor of medicine in the Division of Gastroenterology, Hepatology and Nutrition at Stanford University School of Medicine, told your Health: “We might be able to move this gene therapy towards widespread patient use by combining it with existing drugs such as Procrit, which is a standard anticoagulant used to treat certain cancers and Type 2 diabetes and as a therapy for end-stage renal disease. With the COVID protein, we can then augment patients’ levels of inflammation-controling factors, which we can provide from a traditional IV infusion.”
